Are Analysts Bearish Chemed Corporation (NYSE:CHE) After Last Week?





September 24, 2017 – By Stephen Andrade







Investors sentiment increased to 1.18 in 2017 Q2. Its up 0.15, from 1.03 in 2017Q1. It is positive, as 10 investors sold Chemed Corporation shares while 87 reduced holdings. 35 funds opened positions while 79 raised stakes. 15.27 million shares or 1.39% less from 15.49 million shares in 2017Q1 were reported.
Susquehanna Intll Grp Inc Ltd Liability Partnership holds 0% or 13,132 shares. Fifth Third State Bank reported 1,302 shares stake. Chicago Equity Prtn Ltd Limited Liability Company accumulated 0.1% or 17,530 shares. Quantitative Invest Management Limited Liability Company accumulated 1,500 shares. Spark Inv Mgmt Ltd Liability Co holds 0.09% in Chemed Corporation (NYSE:CHE) or 6,800 shares. Palo holds 1.03% of its portfolio in Chemed Corporation (NYSE:CHE) for 8,881 shares. Moreover, Assetmark has 0% invested in Chemed Corporation (NYSE:CHE). Stephens Inc Ar owns 1,472 shares. Moreover, Invesco Limited has 0.02% invested in Chemed Corporation (NYSE:CHE) for 367,782 shares. Qs Investors Ltd Llc holds 0% of its portfolio in Chemed Corporation (NYSE:CHE) for 1,962 shares. Voya Invest Mgmt Ltd Liability stated it has 214,764 shares or 0.1% of all its holdings. State Of Alaska Department Of Revenue owns 3,179 shares. Blackrock reported 1.92M shares or 0.02% of all its holdings. Piedmont Investment Advisors Lc invested in 0.02% or 3,477 shares. South Dakota Council reported 5,000 shares stake.

Since March 31, 2017, it had 1 insider buy, and 2 selling transactions for $880,112 activity. $62,615 worth of Chemed Corporation (NYSE:CHE) shares were sold by SAUNDERS DONALD E. 4,000 Chemed Corporation (NYSE:CHE) shares with value of $820,440 were sold by MCNAMARA KEVIN J. WALSH GEORGE J III also bought $2,943 worth of Chemed Corporation (NYSE:CHE) shares.

Chemed Corporation (NYSE:CHE) Ratings Coverage

Among 3 analysts covering Chemed (NYSE:CHE), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Chemed had 13 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, October 26 the stock rating was maintained by Oppenheimer with “Outperform”. RBC Capital Markets maintained the shares of CHE in report on Tuesday, November 1 with “Sector Perform” rating. The stock of Chemed Corporation (NYSE:CHE) earned “Hold” rating by RBC Capital Markets on Tuesday, May 30. On Tuesday, September 22 the stock rating was maintained by Oppenheimer with “Outperform”. The stock of Chemed Corporation (NYSE:CHE) earned “Sector Perform” rating by RBC Capital Markets on Monday, October 26. RBC Capital Markets maintained it with “Sector Perform” rating and $129 target in Monday, July 27 report. The firm has “Buy” rating by Oppenheimer given on Tuesday, July 25. The rating was maintained by RBC Capital Markets on Friday, September 1 with “Hold”. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) on Monday, May 2 with “Sector Perform” rating. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, July 5. Below is a list of Chemed Corporation (NYSE:CHE) latest ratings and price target changes.

01/09/2017 Broker: RBC Capital Markets Rating: Hold New Target: $209.0 Maintain
28/08/2017 Broker: KeyBanc Capital Markets Rating: Sector Weight Initiates Coverage On
30/07/2017 Broker: RBC Capital Markets Rating: Hold New Target: $209.0000 Maintain
25/07/2017 Broker: Oppenheimer Rating: Buy Maintain
05/07/2017 Broker: RBC Capital Markets Rating: Hold New Target: $208.0000 Maintain
30/05/2017 Broker: RBC Capital Markets Rating: Hold New Target: $208.0000 Maintain

The stock increased 0.59% or $1.12 on September 22, reaching $191.86. About 69,717 shares traded. Chemed Corporation (NYSE:CHE) has risen 54.48% since September 24, 2016 and is uptrending. It has outperformed by 37.78% the S&P500.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The company has market cap of $3.07 billion. The Firm operates through two divisions: the VITAS segment and the Roto-Rooter segment (Roto-Rooter). It has a 48.17 P/E ratio. The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

More notable recent Chemed Corporation (NYSE:CHE) news were published by: Businesswire.com which released: “Chemed Corporation Increases Quarterly Dividend 7.7%” on August 04, 2017, also Seekingalpha.com with their article: “Chemed’s (CHE) CEO Kevin McNamara on Q1 2017 Results – Earnings Call Transcript” published on April 27, 2017, Seekingalpha.com published: “Chemed: Hospice And…Plumbing?” on April 04, 2017. More interesting news about Chemed Corporation (NYSE:CHE) were released by: Businesswire.com and their article: “Chemed Corporation to Present at the Jefferies 2017 Global Healthcare Conference” published on May 31, 2017 as well as Seekingalpha.com‘s news article titled: “Chemed’s (CHE) CEO Kevin McNamara on Q4 2016 Results – Earnings Call Transcript” with publication date: February 16, 2017.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *

*

19 − sixteen =